Sanovas is developing the next generation of minimally invasive surgical tools and technologies. Our revolutionary, patented products enable surgeons to visualize, diagnose, measure and treat obstructed passageways in areas of the body that are inaccessible using currently marketed surgical tools. These products are designed to provide surgeons with faster, less invasive, lower risk and more cost effective interventional treatments. The company is initially targeting the pulmonary market, which includes treatment of lung cancer, COPD, asthma and cystic fibrosis. Future addressable markets include treatment of diseases and disorders of the six major organ systems of the tubular anatomy. At the heart of Sanovas’ scientific advancements is the miniaturization of tools for minimally invasive surgery. Sanovas’ products extend access beyond current limits enabling surgeons to perform therapeutic intervention in small, one-millimeter diameter regions of the anatomy that were previously inaccessible and heretofore not possible to access.
Company Growth (employees)
Type
Private
HQ
San Rafael, US
Founded
2009
Size (employees)
29 (est)+8%
Sanovas was founded in 2009 and is headquartered in San Rafael, US

Key People at Sanovas

Larry Gerrans

Larry Gerrans

President & CEO
Robert E. Farrell

Robert E. Farrell

CFO
Erhan Gunday

Erhan Gunday

CTO

Sanovas Office Locations

Sanovas has an office in San Rafael
San Rafael, US (HQ)
2597 Kerner Blvd

Sanovas Data and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$6.7 m

Latest funding size

$285.7 k

Time since last funding

almost 2 years
Sanovas's latest funding round in October 2015 was reported to be $285.7 k. In total, Sanovas has raised $6.7 m

Sanovas Online and Social Media Presence

Sanovas Company Life and Culture

You may also be interested in